Mortality and Attrition Rates within the First Year of Antiretroviral Therapy Initiation among People Living with HIV in Guangxi, China: An Observational Cohort Study
Open Access
- 10 February 2021
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2021, 1-10
- https://doi.org/10.1155/2021/6657112
Abstract
Objective. To assess the mortality and attrition rates within the first year of antiretroviral therapy (ART) initiation among people living with human immunodeficiency virus (PLHIV) in rural Guangxi, China. Design. Observational cohort study. Setting. The core treatment indicators and data were collected with standard and essential procedures as per the Free ART Manual guidelines across all the rural health care centers of Guangxi. Participants. 58,115 PLHIV who were under ART were included in the study. Interventions. The data collected included sociodemographic characteristics that consist of age, sex, marital status, route of HIV transmission, CD4 cell count before ART, initial ART regimen, level of ART site, and year of ART initiation. Primary and Secondary Outcome Measures. Mortality and attrition rate following ART initiation. Results. The average mortality rate was 5.94 deaths, and 17.52 attritions per 100 person-years within the first year of ART initiation among PLHIV. The mortality rate was higher among intravenous drug users (Adjusted Hazard Ratio (AHR) 1.27, 95 Confidence Interval (CI) 1.14-1.43), prefecture as a level of ART site (AHR 1.14, 95 CI 1.02-1.28), and county as the level of ART site (AHR 2.12, 95 CI 1.90-2.37). Attrition was higher among intravenous drug users (AHR 1.87, 95 CI 1.75-2.00), the first-line ART containing AZT (AHR 1.09, 95 CI 1.03-1.16), and first-line ART containing LVP/r (AHR 1.34, 95 CI 1.23-1.46). Conclusion. The mortality and attrition rates were both at the highest level in the first year of post-ART; continued improvement in the quality of HIV treatment and care is needed.Keywords
Funding Information
- Chinese State Key Laboratory of Infectious Disease Prevention and Control (2017ZX10201101, 2018ZX10721102-006, AB16380213, 91546203, 81360442, 81460510, 81502862, 11971479, Z20170126)
This publication has 44 references indexed in Scilit:
- Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug usersAIDS, 2013
- Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort studyThe Lancet, 2013
- Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort StudyPLoS Medicine, 2012
- Poorer ART Outcomes with Increasing Age at a Large Public Sector HIV Clinic in Johannesburg, South AfricaJournal of the International Association of Physicians in AIDS Care, 2011
- Gender Difference in 2-Year Mortality and Immunological Response to ART in an HIV-Infected Chinese Population, 2006–2008PLOS ONE, 2011
- Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy ProgramPLOS ONE, 2011
- HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985–2008PLOS ONE, 2010
- Predictors of Virologic Failure in HIV‐1–Infected Adults Receiving First‐Line Antiretroviral Therapy in 8 Provinces in ChinaClinical Infectious Diseases, 2010
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAIDS, 2010
- Cohort Profile: The Chinese national free antiretroviral treatment cohortInternational Journal of Epidemiology, 2009